Global Cord Blood Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Global Cord Blood.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 15.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Global Cord Blood GAAP EPS of $0.14, revenue of $46.88M
Jul 05Pounce On Global Cord For The Year Of The Tiger
Apr 29Global Cord Blood Corp. Looks Anemic On Slow Growth, Regulatory Concerns
Apr 08Global Cord Blood: With 6.0x P/E And 24% EPS CAGR, Subscriber Growth Continues
Dec 01Global Cord Blood Is An Undervalued Business With Accelerating Growth, Benefiting From China's Policy Changes
Jul 30Global Cord Blood: New China Policy Catalyst, 146% Net Cash And 24% EPS CAGR
Jul 01Global Cord Blood announces NHC policy update
Jan 05Global Cord Blood reports FQ2 results
Nov 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Global Cord Blood has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2022 | 1,243 | 501 | 594 | 614 | N/A |
| 12/31/2021 | 1,248 | 524 | N/A | N/A | N/A |
| 9/30/2021 | 1,222 | 506 | 670 | 686 | N/A |
| 6/30/2021 | 1,194 | 512 | N/A | N/A | N/A |
| 3/31/2021 | 1,160 | 508 | 610 | 631 | N/A |
| 12/31/2020 | 1,157 | 478 | N/A | N/A | N/A |
| 9/30/2020 | 1,201 | 506 | 498 | 521 | N/A |
| 6/30/2020 | 1,229 | 495 | N/A | N/A | N/A |
| 3/31/2020 | 1,221 | 471 | 600 | 624 | N/A |
| 12/31/2019 | 1,173 | 465 | N/A | N/A | N/A |
| 9/30/2019 | 1,093 | 381 | 756 | 783 | N/A |
| 6/30/2019 | 1,026 | 326 | N/A | N/A | N/A |
| 3/31/2019 | 987 | 291 | 761 | 792 | N/A |
| 12/31/2018 | 968 | 231 | N/A | N/A | N/A |
| 9/30/2018 | 959 | 239 | 703 | 764 | N/A |
| 6/30/2018 | 946 | 242 | N/A | N/A | N/A |
| 3/31/2018 | 937 | 237 | 752 | 819 | N/A |
| 12/31/2017 | 906 | 235 | N/A | N/A | N/A |
| 9/30/2017 | 862 | 221 | 784 | 812 | N/A |
| 6/30/2017 | 811 | 170 | N/A | N/A | N/A |
| 3/31/2017 | 760 | 116 | 613 | 638 | N/A |
| 12/31/2016 | 715 | 96 | N/A | N/A | N/A |
| 9/30/2016 | 683 | 91 | 524 | 550 | N/A |
| 6/30/2016 | 671 | 93 | N/A | N/A | N/A |
| 3/31/2016 | 663 | 91 | 564 | 581 | N/A |
| 12/31/2015 | 669 | 87 | N/A | N/A | N/A |
| 9/30/2015 | 667 | 79 | N/A | 598 | N/A |
| 6/30/2015 | 647 | 83 | N/A | N/A | N/A |
| 3/31/2015 | 635 | 99 | N/A | 595 | N/A |
| 12/31/2014 | 624 | 107 | N/A | N/A | N/A |
| 9/30/2014 | 608 | 116 | N/A | 602 | N/A |
| 6/30/2014 | 597 | 115 | N/A | N/A | N/A |
| 3/31/2014 | 573 | 117 | N/A | 536 | N/A |
| 12/31/2013 | 554 | 109 | N/A | N/A | N/A |
| 9/30/2013 | 553 | 106 | N/A | 529 | N/A |
| 6/30/2013 | 540 | 106 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CORB.F's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if CORB.F's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if CORB.F's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CORB.F's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if CORB.F's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CORB.F's Return on Equity is forecast to be high in 3 years time